Found 288 matching trials
Bela 8 Week Dosing PHASE4 The purpose of this study is to transition patients who have been stable on...
Show More Learn More & Join Trial
Subcutaneous Pharmacokinetics of Belatacept PHASE1 Pharmacokinetics, Bioavailability, Safety and Immunogenicity of Single Dose...
Show More Learn More & Join Trial
Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy PHASE2 This is a phase 2a, multi-center, randomized and double-blind placebo-contr...
Show More Location
CHU Sainte-Justine
Learn More & Join Trial
A Study to Assess the Pharmacokinetics, Immunogenicity and Safety of Escalating Doses of BMS-188667 Given as a Single Intravenous Infusion to Patients With Psoriasis Vulgaris PHASE1 The purpose of this protocol is to determine the single-dose pharmacokineti...
Show More Location
California Clinical Trials Medical Group
Learn More & Join Trial
Belatacept to Prevent Organ Rejection in Kidney Transplant Patients PHASE2 Belatacept is an experimental medication shown in clinical trials to have i...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Immune Monitoring to Facilitate Belatacept Monotherapy PHASE4 * To determine the utility of novel blood-based immune monitoring tools (Al...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV) PHASE4 Pemphigus vulgaris (PV) is a rare, chronic, debilitating, and potentially l...
Show More Learn More & Join Trial
Phase I-II PTCy, Bortezomib and Sitagliptin for Prevention of GvHD Following Allogeneic HSCT PHASE1 Phase I-II studying post transplant cyclophosphamide, bortezomib and sitagl...
Show More Learn More & Join Trial
Belatacept in Renal Transplantation With Intermediate Risk Maryland Aggregate Pathology Index (MAPI) Scores NA This will be a pilot study to investigate the use of belatacept (BMS) thera...
Show More Location
University of Maryland
Learn More & Join Trial
Using Adalimumab Serum Concentration to Choose a Subsequent Biological DMARD in Rheumatoid Arthritis Patients Failing Adalimumab Treatment PHASE4 A potential application of therapeutic drug monitoring is to predict effica...
Show More Location
Sint Maartenskliniek
Learn More & Join Trial